Effectiveness of Intensive Endoscopic Screening for Esophageal Cancer in China: A Community-Based Study

Abstract Evidence is required to evaluate the effectiveness of population-level endoscopic screening for esophageal cancer (EC). In this study, 5,632 permanent residents aged 25–65 years from 6 villages in Hua County, Henan Province, China, were defined as the screening cohort and were offered inten...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of epidemiology Vol. 188; no. 4; pp. 776 - 784
Main Authors Liu, Mengfei, He, Zhonghu, Guo, Chuanhai, Xu, Ruiping, Li, Fenglei, Ning, Tao, Pan, Yaqi, Li, Yong, Ding, Huirong, Zheng, Li, Zhou, Yue, Tian, Xiuyun, Yang, Wenjun, Wang, Xueqian, Lu, Fang, Zhang, Yanyan, Zhao, Yiqiang, Guo, Fangcen, Chen, Ke, Gao, Lei, Sun, Min, Liu, Ying, Liu, Fangfang, Hang, Dong, Shen, Na, Li, Jingjing, Xu, Zhongyao, Wang, Qiyan, Zhang, Chanyuan, Abliz, Amir, Deng, Qiuju, Li, Xiang, Liu, Zhen, Zhang, Chaoting, Yuan, Wenqing, Wang, Hui, Weiss, Noel S, Cai, Hong, Ke, Yang
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 01.04.2019
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Evidence is required to evaluate the effectiveness of population-level endoscopic screening for esophageal cancer (EC). In this study, 5,632 permanent residents aged 25–65 years from 6 villages in Hua County, Henan Province, China, were defined as the screening cohort and were offered intensive endoscopic screening. Residents of all 914 remaining villages in Hua County were included as the control cohort, and age-sex standardization was used to calculate the expected numbers of EC and upper gastrointestinal (GI) tract cancer cases and deaths in the screening cohort. The effectiveness of screening was assessed by comparing observed numbers of cases and deaths with expected numbers after 9-year follow-up of these screened subjects (2007–2016). In the screening cohort, 23 upper GI cancers (including 16 ECs) and 10 upper GI cancer deaths (including 5 EC deaths) were identified, and 47% (standardized incidence ratio = 0.53, 95% confidence interval (CI): 0.33, 0.87) and 66% (standardized mortality ratio = 0.34, 95% CI: 0.14, 0.81) reductions in cumulative EC incidence and mortality were found. For upper GI cancers, incidence and mortality were lowered by 43% (standardized incidence ratio = 0.57, 95% CI: 0.38, 0.86) and 53% (standardized mortality ratio = 0.47, 95% CI: 0.25, 0.88), respectively. This study showed that upper GI tract endoscopy is an effective population-level screening test for EC in high-risk regions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ISSN:0002-9262
1476-6256
1476-6256
DOI:10.1093/aje/kwy291